Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant follicle stimulating hormone + ganirelix
- Development stage
- Unknown
- Lead developer
- Organon
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Administration
- Subcutaneous
01
Overview
**Recombinant follicle stimulating hormone + ganirelix** is a combination regimen used during assisted reproductive technology (ART), particularly in in vitro fertilization (IVF) protocols. Recombinant follicle stimulating hormone (FSH) is a synthetic version of the naturally occurring hormone that stimulates ovarian follicle development in women and spermatogenesis in men. Ganirelix is a synthetic decapeptide and a competitive antagonist of the gonadotropin-releasing hormone (GnRH) receptor, used to prevent premature luteinizing hormone (LH) surges during controlled ovarian hyperstimulation. By combining these agents, clinicians are able to promote follicular growth while tightly controlling ovulation timing, increasing the probability of retrieving multiple mature oocytes for ART procedures.
- Other names
- recombinant FSH + ganirelix
02
Targets
FSHR (Follicle-stimulating hormone receptor)GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on recombinant follicle stimulating hormone + ganirelix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant follicle stimulating hormone + ganirelix.